CJC-1295 research guide

CJC-1295 in Cela — GHRH Analog Research Guide

CJC-1295 research guide for Cela. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

Research-Grade CJC-1295 for Cela Investigators

The pursuit for CJC-1295 in Cela almost always leads to the same conclusion: research peptides are supplied via specialist online vendors, not brick-and-mortar outlets. What this means for Cela researchers is that physical proximity is irrelevant compared to your ability to assess COA data — and those quality checks are within reach of all serious researchers. What genuinely separates top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for contamination assurance. What follows is a practical research guide built specifically around CJC-1295, covering everything a Cela researcher needs to evaluate quality systematically.

What Studies Say About CJC-1295

CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Cela comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.

How to Source CJC-1295 — Vendor Guide

Quality CJC-1295 sourcing begins with a straightforward question: does this vendor publish batch-specific COAs proactively? Those who make this data freely available are demonstrating research-grade standards. The HPLC purity trace is the most important document in the COA: it should show a clear dominant peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be 98% or higher. Strong quality indicators beyond COA quality: established track record of at least two years, customer service that can discuss analytical methods, and temperature-appropriate packaging with desiccant. Bacteriostatic water is the appropriate reconstitution medium for CJC-1295 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 30 days refrigerated.

Order CJC-1295 — ships to Cela
COA-verified · International tracking · Research grade
Order Now →

Safe Research Practices for CJC-1295

As a research compound, CJC-1295 has not undergone the clinical trial process required for pharmaceutical approval — its safety profile is defined by animal study data and limited human studies. Temperature excursions — even temporary temperature deviation — can partially degrade CJC-1295 without detectable changes to appearance; always maintain cold chain and work with cold-shipped material. Verify the endotoxin level in your CJC-1295 batch COA before any injectable research application — look for results expressed as EU/mg or EU/mL and verify they are within the acceptable range for your research context. The research literature on CJC-1295 should be studied thoroughly before designing any protocol — study designs, dosing ranges, and outcome measures vary significantly and conclusions do not uniformly extrapolate.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →